Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 6/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 4/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 4/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27367847 | 1.00 | EPHX2 (0.38) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| SCHEMBL20067101 | 1.00 | EPHX2 (0.38) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| SCHEMBL19588665 | 1.00 | EPHX2 (0.38) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| SCHEMBL20077560 | 1.00 | EPHX2 (0.38) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| SCHEMBL30985685 | 0.98 | EPHX2 (0.37) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| SCHEMBL31296126 | 0.98 | EPHX2 (0.37) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| Iodide SCHEMBL237045 | 0.98 | EPHX2 (0.37) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| SCHEMBL30454549 | 0.98 | EPHX2 (0.37) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| SCHEMBL31373110 | 0.98 | EPHX2 (0.37) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D | |
| Bromide SCHEMBL28905083 | 0.98 | EPHX2 (0.37) | EPHX2HSD11B1KMT2ASMN1; SMN2GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5408 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637412-B2 | Preparation of aromatic carboxyamides by a palladium-catalyzed carbonylation reaction | BASF SE (DE) | 2026-05-26 | — | — | US | claimed |
| WO-2026086030-A1 | METHOD FOR CONSTRUCTING CHIRALITY OF PYRAN RING IN ORFORGLIPRON BY MEANS OF ENZYMATIC CATALYSIS | 成都安迈博生物医药有限公司 | 2026-04-30 | — | — | WO | claimed |
| EP-4714955-A1 | VERSATILE INTERMEDIATE FOR OPIOID DERIVATIVES, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shaoxing Zejun Pharmaceuticals Co., Ltd (CN) | 2026-03-25 | — | — | EP | claimed |
| US-20260062361-A1 | PROCESS FOR THE PREPARATION OF BIO-BASED OLEFINS FROM PRIMARY ALCOHOL | BASF SE (DE) | 2026-03-05 | — | — | US | claimed |
| EP-4143158-B1 | PREPARATION OF AROMATIC CARBOXYAMIDES BY PALLADIUM-CATALYZED CARBONYLATION REACTION | BASF SE (DE) | 2025-10-01 | — | — | EP | claimed |
| EP-4594306-A1 | SYNTHESIS METHODS AND INTERMEDIATES FOR THE PRODUCTION OF REMIBRUTINIB | Novartis AG (CH) | 2025-08-06 | — | — | EP | claimed |
| EP-4585268-A2 | SOLID FORMS OF ISOQUINOLINONE DERIVATIVES, PROCESS OF MAKING, COMPOSITIONS COMPRISING, AND METHODS OF USING THE SAME | Twelve Therapeutics, Inc. (US) | 2025-07-16 | — | — | EP | claimed |
| US-20250206723-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC | 2025-06-26 | — | — | US | claimed |
| EP-4574808-A1 | PROCESS FOR THE HYDROFORMYLATION OF AN ALIPHATIC ALKENE | Université de Strasbourg (FR) | 2025-06-25 | — | — | EP | claimed |
| EP-4568984-A1 | PROCESS FOR MANUFACTURING AN ANTIBIOTIC MACROCYCLIC PEPTIDE | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | claimed |
| WO-2011041284-A1 | PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS | THERAVANCE, INC. (US) | 2011-04-07 | — | — | WO | claimed |
| US-20110077411-A1 | PROCESS FOR PREPARING BIPHENYL IMIDAZOLE COMPOUNDS | THERAVANCE BIOPHARMA R&D IP, LLC | 2011-03-31 | — | — | US | claimed |
| WO-2010128316-A1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2010-11-11 | — | — | WO | claimed |
| EP-1303525-B1 | PRODUCTION OF NOVEL PHOSPHANE LIGANDS AND USE IN CATALYTICAL REACTIONS | EVONIK DEGUSSA GMBH (DE) | 2010-09-08 | — | — | EP | claimed |
| US-20090163712-A1 | PROCESSES FOR PREPARING HIV REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2009-06-25 | — | — | US | claimed |
| US-20090111962-A1 | Palladium Complexes and Polymerization and Coupling Processes Thereof | WEST CHESTER UNIVERSITY OF PENNSYLVANIA OF THE STATE SYSTEM OF HIGHER EDUCATION | 2009-04-30 | — | — | US | claimed |
| US-20090012293-A1 | USE OF ARYL CHLORIDES IN PALLADIUM-CATALYZED C-H BOND FUNCTIONALIZATION | THE UNIVERSITY OF HOUSTON SYSTEM (US) | 2009-01-08 | — | — | US | claimed |
| WO-2006043121-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | RANBAXY LABORATORIES LIMITED (IN) | 2006-04-27 | — | — | WO | claimed |
| WO-2006035283-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | RANBAXY LABORATORIES LIMITED (IN) | 2006-04-06 | — | — | WO | claimed |
| US-6686495-B2 | IN PRESENCE OF PALLADIUM CATALYST; USEFUL IN PRODUCING CHEMICAL INTERMEDIATES FOR PHARMACEUTICALS, OPTICAL BRIGHTENING AGENTS AND AGROCHEMICALS | OMG AG & CO KG (DE) | 2004-02-03 | — | — | US | claimed |